In this Section
231316 Prevalence of Hepatitis C Virus infection among persons who inject drug in 4 cities, US, 2009
Tuesday, November 9, 2010 : 9:20 AM - 9:35 AM
HCV infection is a common blood borne infection with an estimated 4 million persons infected in the US. Prevalence of HCV infection in persons who inject drugs can reach up to 90% depending on duration and frequency of injection and injection-related behaviors. In 2009, we conducted a serological survey in 4 US cities to determine the prevalence and correlates of HCV infection among persons who report injecting drugs in the past 12 months. The study examined data from 4 cities (NYC, Dallas, Denver, and Seattle) that participated in the National HIV Behavioral Surveillance System. Participants were recruited using Respondent Driven Sampling. In addition to behavioral risk factor survey data, testing for HIV and HCV was conducted. Of the 1714 persons who had an HCV test the prevalence of HCV infection was 78.4% (Seattle (72.8%), Denver (73.0%), NYC (75.5%), and Dallas (89.1%). The characteristics of the population, prevalence of injection-related behaviors, and HCV infection prevalence by such characteristics will be presented in detail. Prevalence of behaviors associated with HCV transmission and prevalence of HCV infection continue to be a significant problem among persons who inject drugs.
Public health or related public policy
Public health or related research
Social and behavioral sciences
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I participated in the design, conduct of study and analysis of data.
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.